Focal nodular hyperplasia is a benign liver tumour that is rare in children. We report the second case of a child with sickle ceil disease presenting with symptomatic focal nodular hyperplasia. The possible pathogenesis of focal nodular hyperplasia and the association with sickle ceil disease are discussed.
Focal nodular hyperplasia of the liver is a rare benign lesion found predominantly in women during their reproductive years.' It consists of a well circumscribed area of hyperplastic liver parenchyma that may contain a stellate fibrous scar. The lesion is usually asymptomatic and is an incidental finding. We describe a patient with sickle cell disease presenting with a symptomatic lesion of focal nodular hyperplasia. This is the second description of such an association2 and we discuss whether sickle cell disease is a pathogenetic mechanism for the development of focal nodular hyperplasia.
expanding portal tracts that contained dilated vascular channels and numerous bile ductules was typical of focal nodular hyperplasia (fig 3) .
Discussion
Focal nodular hyperplasia is a rare benign liver tumour with fewer than 20% of cases presenting in children. 3 The majority are asymptomatic and usually arise on the surface of the liver beneath the capsule. Their aetiology is unknown, although an association with oral contraceptives has been reported. 4 The radiological diagnosis depends on identification by ultrasound 1) and was shown to be avascular on hepatic angiography (fig 2) .
At operation, after exchange transfusion, the solid mass was found to be restricted to segments 2 and 3 of the left lobe and was resected. She was discharged home on the ninth postoperative day.
The cut surface of the tumour was smooth with focal areas of haemorrhage, but there was no stellate scar. The microscopic appearance of fibrous bands transecting liver tissue with transected by fibrous bands with expanded portal tracts (thick arrow) containing dilated vascular channels and bile ductules (magnificationx100). vessels which produce a dense capillary blush are diagnostic but uncommon.5
The management of asymptomatic lesions should be to confirm the diagnosis of focal nodular hyperplasia by liver biopsy, excluding benign lesions such as hepatic adenoma, mesenchymal hamartoma, or haemangioma and malignant lesions such as fibrolamellar carcinoma. Ultrasound follow up has been suggested. Symptoms may settle by withdrawal of oral contraceptives, but in other patients symptomatic lesions should be resected or if this is not possible they can be embolised. ' The pathogenesis of focal nodular hyperplasia has been considered to be neoplastic, hamartomatous, or a response to ischaemia or other focal injury. It has been suggested that the lesions arise as a hyperplastic response of liver parenchyma to differential blood flow caused by a pre-existing arterial malformation. 
